外体生产和动脉样硬化之间的关系的进展
Yi Yang1, Jinxi Luo1, Yunan Kang2
1Clinical Medical School, Weifang Medical University, Weifang, Shandong, 261053, P.R. China.
Current pharmaceutical biotechnology
|July 26, 2023
概括
外体,微小的带有分子的囊泡,越来越多地与动脉样硬化 (AS) 的进展有关. 了解它们的作用为AS预防,诊断和治疗提供了新的途径.
科学领域:
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 动脉样硬化 (AS) 是心血管疾病的主要原因,给人带来很大的负担.
- 外体是参与细胞间通信的脂质双层微,提供生物活性分子.
- 最近的研究澄清了外体和动脉样硬化病原体之间的相关性.
研究的目的:
- 审查外体的组成,生物发生和释放机制.
- 总结目前对动脉样硬化中的外体的研究.
- 在AS进展过程中探索外体源分子,如miRNAs.
主要方法:
- 文献综述侧重于外体生物发生,提取和AS中的作用.
- 对外体组合的分析,包括核酸和蛋白质.
- 在动脉样硬化中对外体-miRNA相互作用的最新发现的综合.
主要成果:
- 外基因组富含核酸和蛋白质,外基因组的miRNA在AS中发挥着关键作用.
- 外基因组影响细胞通信和内部环境,影响AS.
- 目前的研究强调了外体作为潜在的生物标志物和AS的治疗点.
结论:
- 异构体代表了在动脉样硬化预防,诊断和治疗方面的新策略的一个有希望的领域.
- 对外体函数的进一步研究可以为心血管疾病提供新的治疗点.
- 了解外体机制可以了解疾病状态中的细胞通信.
相关概念视频
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Inflammation
53.9K
Overview
53.9K
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Coronary Artery Disease II: Pathophysiology
13
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13


